Abstract
The ECLS circuit is composed of a variety of specialized devices that must function both separately and in concert to support the patient. As each case and patient demand different solutions, circuits vary in their features. This chapter provides a fund of knowledge regarding these components: what function they provide, the general principles involved, and how to identify device compromise or failure. It therefore serves as a guide for building a circuit for each patient; balancing the various needs at hand requires an understanding of such matters. Also discussed are priming of the circuit and patient-circuit interactions such as drug adsorption and inflammation due to blood-surface interaction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Khoshbin E, Dux AEW, Killer H, Sosnowski AW, Firmin RK, Peek GJ. A comparison of radiographic signs of pulmonary inflammation during ECMO between silicon and poly-methyl pentene oxygenators. Perfusion. 2007;22:15–22.
Peek GJ, Firmin RK. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J. 1999;45(4):250–63.
Lehle K, Philipp A, Gleich O, et al. Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J. 2008;54(6):612–7. https://doi.org/10.1097/MAT.0b013e318186a807.
Wildschut ED, Ahsman MJ, Allegaert K, Mathot RAA, Tibboel D. Determinants of drug absorption in different ECMO circuits. Intensive Care Med. 2010;36:2109–16.
Lawson DS, Ing R, Cheifetz IM, et al. Hemolytic characteristics of three commercially available centrifugal blood pumps. Pediatr Crit Care Med. 2005;6(5):573–7. https://doi.org/10.1097/01.pcc.0000163282.63992.13.
Burnside J, Gomez D, Preston TJ, Olshove VF, Phillips A. In-vitro quantification of gaseous microemboli in two extracorporeal life support circuits. J Extra Corpor Technol. 2011;43:123–9.
Yee S, Qiu F, Su X, et al. Evaluation of HL-20 roller pump and Rotaflow centrifugal pump on perfusion quality and gaseous microemboli delivery. Artif Organs. 2010;34(11):937–43. https://doi.org/10.1111/j.1525-1594.2010.01079.x.
Lawson DS, Lawson AF, Walczak R, et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices and team roles: 2008 survey results of Extracorporeal Life Support Organization (ELSO) centers. J Extra Corpor Technol. 2008;40(3):166–74.
Lawson DS, Walczak R, Lawson AF, et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results. J Extra Corpor Technol. 2004;36(1):16–21.
Drinker PA, Bartlett RH, Rishon MB, Noyes BS. Augmentation of membrane gas transfer by induced secondary flows. Surgery. 1969;66(4):775–81.
Diller TE, Mikic BB, Drinker PA. Shear-induced augmentation of oxygen transfer in blood. J Biomech Eng. 1980;102:67–72.
Gaylor JDS. Membrane oxygenators: current developments in design and application. J Biomed Eng. 1988;10:541–7.
Mueller T, Lubnow M, Philipp A, et al. Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. Eur Respir J. 2009;33:551–9.
Johnson P, Frohlich S, Westbrook A. Use of extracorporeal membrane lung assist device (Novalung) in H1N1 patients. J Card Surg. 2011;26(4):449–52. https://doi.org/10.1111/j.1540-8191.2011.01261.x.
Kolobow T, Bowman RL. Construction and evaluation of an alveolar membrane artificial heart-lung. ASAIO J. 1963;9:238–43.
Khoshbin E, Roberts N, Harvey C, et al. Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation. ASAIO J. 2005;51(3):281–7. https://doi.org/10.1097/01.mat.0000159741.33681.f1.
Montoya JP, Shanley CJ, Merz SI, Bartlett RH. Plasma leakage through microporous membranes: role of phospholipids. ASAIO J. 1992;38(M399-M405):M399–405.
Eash HJ, Jones HM, Hattler BG, Federspiel WJ. Evaluation of plasma resistant hollow fiber membranes for artificial lungs. ASAIO J. 2004;50(5):491–7. https://doi.org/10.1097/01.mat.0000138078.04558.fe.
Puis L, Ampe L, Hertleer R. Case report: plasma leakage in a polymethylpentene oxygenator during extracorporeal life support. Perfusion. 2009;24(1):51–2. https://doi.org/10.1177/0267659109106294.
Antonucci E, Lamanna I, Fagnoul D, Vincent JL, De Backer D, Silvio TF. The impact of renal failure and renal replacement therapy on outcome during extracorporeal membrane oxygenation therapy. Artif Organs. 2016;40(8):746–54. https://doi.org/10.1111/aor.12695.
Ostermann M, Connor M Jr, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how? Curr Opin Crit Care. 2018;24(6):493–503. https://doi.org/10.1097/MCC.0000000000000559.
Fosse E, Moen O, Johnson E, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 1994;58:472–7.
Jansen PGM, Velthius H, Huybregts RAJM, et al. Reduced complement activation and improved postoperative performance after CPB with heparin-coated circuits. J Thorac Cardiovasc Surg. 1995;110:829–34.
Pekna M, Hagman L, Halden E, Nilsson UR, Nilsson B, Thelin S. Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Ann Thorac Surg. 1994;58:421–4.
Gravlee GP. Heparin-coated cardiopulmonary bypass circuits. J Cardiothorac Vasc Anesth. 1994;8(2):213–22.
Gu YJ, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CRH. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:917–22.
Ranucci M, Ballotta A, Kandil H, et al. Bivalrudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation. Crit Care. 2011;15:R275.
Silvetti S. Do we need heparin coating for extracorporeal membrane oxygenation? New concepts and controversial positions about coating surfaces of extracorporeal circuits. Artif Organs. 2015;39:176–9.
Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost. 2014;40:106–14.
Pollak U, Yacobobich J, Tamary H, Dagan O, Manor-Shulman O. Heparin-induced thrombocytopenia and extracorporeal membrane oxygenation: a case report and review of the literature. J Extra Corpor Technol. 2011;43(1):5–12.
Beiderlinden M, Treschan T, Gorlinger K, Peters J. Argatroban in extracorporeal membrane oxygenation. Artif Organs. 2007;31(6):461–5.
Pappalardo F, Maj G, Scandroglio A, Sampietro F, Zangrillo A, Koster A. Bioline heparin-coated ECMO with bivalirudin anticoagulation in a patient with acute heparin-induced thrombocytopenia: the immune reaction appeared to continue unabated. Perfusion. 2009;24:135–7.
Acknowledgements
The author wishes to thank the following content consultants:
Kristina L. Rudolph, B.S.N.; Jennifer Crumley, M.S.N.; Tom Rath, C.C.P.; and Elizabeth Moore, M.S.N.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rosen, B.H. (2022). Circuits, Membranes, and Pumps. In: Schmidt, G.A. (eds) Extracorporeal Membrane Oxygenation for Adults. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-031-05299-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-031-05299-6_2
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-031-05298-9
Online ISBN: 978-3-031-05299-6
eBook Packages: MedicineMedicine (R0)